These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 30959827)
1. Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling. Choi GW; Lee YB; Cho HY Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30959827 [TBL] [Abstract][Full Text] [Related]
2. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Caldwell GW; Masucci JA; Yan Z; Hageman W Eur J Drug Metab Pharmacokinet; 2004; 29(2):133-43. PubMed ID: 15230342 [TBL] [Abstract][Full Text] [Related]
3. Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with in Vitro-in Vivo Extrapolation and Allometric Scaling. Naritomi Y; Sanoh S; Ohta S Biol Pharm Bull; 2019; 42(3):327-336. PubMed ID: 30828063 [TBL] [Abstract][Full Text] [Related]
4. DallphinAtoM: Physiologically based pharmacokinetics software predicting human PK parameters based on physicochemical properties, in vitro and animal in vivo data. Choi S; Han S; Lee SJ; Lim B; Bae SH; Han S; Yim DS Comput Methods Programs Biomed; 2022 Apr; 216():106662. PubMed ID: 35151112 [TBL] [Abstract][Full Text] [Related]
5. Scaling approaches for the prediction of human clearance of LNA-i-mir-221: A retrospective validation. Fonsi M; Fulbert J; Billat PA; Arbitrio M; Tagliaferri P; Tassone P; Di Martino MT Curr Res Pharmacol Drug Discov; 2024; 7():100197. PubMed ID: 39188553 [TBL] [Abstract][Full Text] [Related]
6. Dose Prediction and Pharmacokinetic Simulation of XZP-5610, a Small Molecule for NASH Therapy, Using Allometric Scaling and Physiologically Based Pharmacokinetic Models. Zhang L; Feng F; Wang X; Liang H; Yao X; Liu D Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543155 [TBL] [Abstract][Full Text] [Related]
7. Inter-Species Pharmacokinetic Modeling and Scaling for Drug Repurposing of Pyronaridine and Artesunate. Kang DW; Kim JH; Kim KM; Cho SJ; Choi GW; Cho HY Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000107 [TBL] [Abstract][Full Text] [Related]
8. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development. Mahmood I Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864 [TBL] [Abstract][Full Text] [Related]
9. The application of allometric scaling principles to predict pharmacokinetic parameters across species. Huang Q; Riviere JE Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1241-53. PubMed ID: 24984569 [TBL] [Abstract][Full Text] [Related]
10. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling. Sanwald-Ducray P; Dow J Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532 [TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols. Mahmood I; Balian JD Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339 [TBL] [Abstract][Full Text] [Related]
12. Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human Clearance. Mahmood I Antibodies (Basel); 2021 Jan; 10(1):. PubMed ID: 33430196 [TBL] [Abstract][Full Text] [Related]
13. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry. Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631 [TBL] [Abstract][Full Text] [Related]
14. To scale or not to scale: the principles of dose extrapolation. Sharma V; McNeill JH Br J Pharmacol; 2009 Jul; 157(6):907-21. PubMed ID: 19508398 [TBL] [Abstract][Full Text] [Related]
15. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia. Larsen MS; Juul RV; Groth AV; Simonsson USH; Kristensen AT; Knudsen T; Agersø H; Kreilgaard M Eur J Pharm Sci; 2018 Mar; 115():196-203. PubMed ID: 29369801 [TBL] [Abstract][Full Text] [Related]
16. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals. Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044 [TBL] [Abstract][Full Text] [Related]
17. Interspecies scaling and comparisons in drug development and toxicokinetics. Ings RM Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215 [TBL] [Abstract][Full Text] [Related]
18. Prediction of clinical pharmacokinetic parameters of linezolid using animal data by allometric scaling: applicability for the development of novel oxazolidinones. Bhamidipati RK; Dravid PV; Mullangi R; Srinivas NR Xenobiotica; 2004 Jun; 34(6):571-9. PubMed ID: 15277016 [TBL] [Abstract][Full Text] [Related]
19. ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Chaira T; Subramani C; Barman TK Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111697 [TBL] [Abstract][Full Text] [Related]
20. Development of a hybrid physiologically based pharmacokinetic model with drug-specific scaling factors in rat to improve prediction of human pharmacokinetics. Sayama H; Komura H; Kogayu M; Iwaki M J Pharm Sci; 2013 Nov; 102(11):4193-204. PubMed ID: 24018828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]